Skip to main content
. 2023 Jan 26;13:1063183. doi: 10.3389/fonc.2023.1063183

Figure 2.

Figure 2

Summary of ongoing adjuvant immunotherapy clinical trials. ALK, anaplastic lymphoma kinase; Chemo, chemotherapy; EGFR, epidermal growth factor receptor; ICI, immune checkpoint inhibitor.